Quarterly report pursuant to Section 13 or 15(d)

Research and Development (Details Narrative)

v3.24.2.u1
Research and Development (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Research and development expense $ 48,000 $ 47,000 $ 95,000 $ 101,000  
Interest and financing expense 84,000 79,000 160,000 173,000  
Accounts payable - licensing agreement 2,315,000   2,315,000   $ 2,198,000
Revenues 0 $ 0 0 0  
License Agreements [Member]          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Revenues     0 0  
AOT Prototys [Member]          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Research and development expense     1,000 6,000  
Temple University License Agreements [Member]          
Research and Development Arrangement, Contract to Perform for Others [Line Items]          
Research and development expense     94,000    
Interest and financing expense     24,000 $ 24,000  
Accounts payable - licensing agreement $ 2,315,000   $ 2,315,000   $ 2,198,000
Temple licensing agreement terms     With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $2,180,000 are deemed past due.